Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 66 Buyback Yield % is -1.28 as of Aug. 03, 2026. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 38 Medical Distribution companies, Leoclan Co ranks worse than 68.42% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Leoclan Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7681 vs MCK, COR, CAH: Buyback Yield % Comparison
For the Medical Distribution subindustry, Leoclan Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Leoclan Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leoclan Co (TSE:7681) has a Buyback Yield % of -1.28 as of Aug. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Leoclan Co and its competitors. According to the industry distribution chart, Leoclan Co ranks #26 out of 38 companies in the Medical Distribution industry, placing it in the top 68.4%.
Is Leoclan Co's Buyback Yield % too high?
Leoclan Co's current Buyback Yield % is -1.28. Based on the distribution chart, Leoclan Co ranks #26 out of 38 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's Buyback Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #26 out of 38 companies for Buyback Yield %. This places Leoclan Co in the lower half of its industry. The industry median Buyback Yield % is 0.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.02, based on 38 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current Buyback Yield % is -1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current Buyback Yield % is -1.28. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current Buyback Yield % is -1.28 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
Buyback Yield %: -1.28
GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
